Literature DB >> 29580581

Acute Kidney Injury and Progression of Diabetic Kidney Disease.

Samuel Mon-Wei Yu1, Joseph V Bonventre2.   

Abstract

Diabetic kidney disease, commonly termed diabetic nephropathy (DN), is the most common cause of end-stage kidney disease (ESKD) worldwide. The characteristic histopathology of DN includes glomerular basement membrane thickening, mesangial expansion, nodular glomerular sclerosis, and tubulointerstitial fibrosis. Diabetes is associated with a number of metabolic derangements, such as reactive oxygen species overproduction, hypoxic state, mitochondrial dysfunction, and inflammation. In the past few decades, our knowledge of DN has advanced considerably although much needs to be learned. The traditional paradigm of glomerulus-centered pathophysiology has expanded to the tubule-interstitium, the immune response and inflammation. Biomarkers of proximal tubule injury have been shown to correlate with DN progression, independent of traditional glomerular injury biomarkers such as albuminuria. In this review, we summarize mechanisms of increased susceptibility to acute kidney injury in diabetes mellitus and the roles played by many kidney cell types to facilitate maladaptive responses leading to chronic and end-stage kidney disease.
Copyright © 2018 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Diabetic kidney disease; End-stage kidney disease

Mesh:

Year:  2018        PMID: 29580581      PMCID: PMC5898826          DOI: 10.1053/j.ackd.2017.12.005

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  296 in total

1.  Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor.

Authors:  P Y Chuang; Q Yu; W Fang; J Uribarri; J C He
Journal:  Kidney Int       Date:  2007-08-01       Impact factor: 10.612

Review 2.  Endothelial dysfunction as a potential contributor in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Katsuyuki Tanabe; Byron P Croker; Richard J Johnson; Maria B Grant; Tomoki Kosugi; Qiuhong Li
Journal:  Nat Rev Nephrol       Date:  2010-11-02       Impact factor: 28.314

3.  Nephrin Preserves Podocyte Viability and Glomerular Structure and Function in Adult Kidneys.

Authors:  Xuezhu Li; Peter Y Chuang; Vivette D D'Agati; Yan Dai; Rabi Yacoub; Jia Fu; Jin Xu; Oltjon Taku; Prem K Premsrirut; Lawrence B Holzman; John Cijiang He
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

4.  SGLT2 inhibitors: β blockers for the kidney?

Authors:  Richard E Gilbert
Journal:  Lancet Diabetes Endocrinol       Date:  2016-10       Impact factor: 32.069

5.  Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.

Authors:  Vishal S Vaidya; Monika A Niewczas; Linda H Ficociello; Amanda C Johnson; Fitz B Collings; James H Warram; Andrzej S Krolewski; Joseph V Bonventre
Journal:  Kidney Int       Date:  2010-10-27       Impact factor: 10.612

6.  Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.

Authors:  Delma Veron; Kimberly J Reidy; Claudia Bertuccio; Jason Teichman; Guillermo Villegas; Juan Jimenez; Wa Shen; Jeffrey B Kopp; David B Thomas; Alda Tufro
Journal:  Kidney Int       Date:  2010-03-10       Impact factor: 10.612

7.  Apoptosis in the kidneys of patients with type II diabetic nephropathy.

Authors:  D Verzola; M T Gandolfo; F Ferrario; M P Rastaldi; B Villaggio; F Gianiorio; M Giannoni; L Rimoldi; F Lauria; M Miji; G Deferrari; G Garibotto
Journal:  Kidney Int       Date:  2007-09-12       Impact factor: 10.612

8.  Type 1 and type 2 diabetes mellitus and risk of acute kidney injury after coronary artery bypass grafting.

Authors:  Daniel Hertzberg; Ulrik Sartipy; Martin J Holzmann
Journal:  Am Heart J       Date:  2015-08-20       Impact factor: 4.749

Review 9.  Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes.

Authors:  Yoshiro Maezawa; Minoru Takemoto; Koutaro Yokote
Journal:  J Diabetes Investig       Date:  2014-07-11       Impact factor: 4.232

10.  Metformin Protects Against Cisplatin-Induced Tubular Cell Apoptosis and Acute Kidney Injury via AMPKα-regulated Autophagy Induction.

Authors:  Jianzhong Li; Yuan Gui; Jiafa Ren; Xin Liu; Ye Feng; Zhifeng Zeng; Weichun He; Junwei Yang; Chunsun Dai
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

View more
  41 in total

1.  Alterations in the molecular composition of COVID-19 patient urine, detected using Raman spectroscopic/computational analysis.

Authors:  John L Robertson; Ryan S Senger; Janine Talty; Pang Du; Amr Sayed-Issa; Maggie L Avellar; Lacey T Ngo; Mariana Gomez De La Espriella; Tasaduq N Fazili; Jasmine Y Jackson-Akers; Georgi Guruli; Giuseppe Orlando
Journal:  PLoS One       Date:  2022-07-18       Impact factor: 3.752

2.  Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.

Authors:  Stephen Zewinger; Thomas Rauen; Michael Rudnicki; Giuseppina Federico; Martina Wagner; Sarah Triem; Stefan J Schunk; Ioannis Petrakis; David Schmit; Stefan Wagenpfeil; Gunnar H Heine; Gert Mayer; Jürgen Floege; Danilo Fliser; Hermann-Josef Gröne; Thimoteus Speer
Journal:  J Am Soc Nephrol       Date:  2018-10-02       Impact factor: 10.121

3.  Dicer deficiency in proximal tubules exacerbates renal injury and tubulointerstitial fibrosis and upregulates Smad2/3.

Authors:  Zhengwei Ma; Qingqing Wei; Ming Zhang; Jian-Kang Chen; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2018-10-03

4.  l-Serine-modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier.

Authors:  Satoru Matsuura; Hidemasa Katsumi; Hiroe Suzuki; Natsuko Hirai; Hidetaka Hayashi; Kazuhiro Koshino; Takahiro Higuchi; Yusuke Yagi; Hiroyuki Kimura; Toshiyasu Sakane; Akira Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-24       Impact factor: 11.205

Review 5.  Diabetic Kidney Disease: Challenges, Advances, and Opportunities.

Authors:  Ya Chen; Kyung Lee; Zhaohui Ni; John Cijiang He
Journal:  Kidney Dis (Basel)       Date:  2020-03-31

6.  Evaluation of antidiabetic and hypolipidemic activity of Barleria cristata Linn. leaves in alloxan-induced diabetic rats.

Authors:  Mohd Nazam Ansari; Abdulaziz S Saeedan; Sakshi Bajaj; Lakhveer Singh
Journal:  3 Biotech       Date:  2021-03-17       Impact factor: 2.406

Review 7.  Bioactive Components of Salvia and Their Potential Antidiabetic Properties: A Review.

Authors:  Aswir Abd Rashed; Devi-Nair Gunasegavan Rathi
Journal:  Molecules       Date:  2021-05-20       Impact factor: 4.411

8.  Silencing cyclophilin A improves insulin secretion, reduces cell apoptosis, and alleviates inflammation as well as oxidant stress in high glucose-induced pancreatic β-cells via MAPK/NF-kb signaling pathway.

Authors:  Tangying Li; Huibiao Quan; Huachuan Zhang; Leweihua Lin; Qianying Ou; Kaining Chen
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

9.  Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19.

Authors:  Gaetano Alfano; Annachiara Ferrari; Francesco Fontana; Giacomo Mori; Riccardo Magistroni; Marianna Meschiari; Erica Franceschini; Marianna Menozzi; Gianluca Cuomo; Gabriella Orlando; Antonella Santoro; Margherita Digaetano; Cinzia Puzzolante; Federica Carli; Andrea Bedini; Jovana Milic; Irene Coloretti; Paolo Raggi; Cristina Mussini; Massimo Girardis; Gianni Cappelli; Giovanni Guaraldi
Journal:  Clin Exp Nephrol       Date:  2021-07-01       Impact factor: 2.801

Review 10.  Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease.

Authors:  Suyan Duan; Fang Lu; Dandan Song; Chengning Zhang; Bo Zhang; Changying Xing; Yanggang Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.